| Title |
Cannabis and schizophrenia
|
|---|---|
| Published in |
Cochrane database of systematic reviews, October 2014
|
| DOI | 10.1002/14651858.cd004837.pub3 |
| Pubmed ID | |
| Authors |
Benjamin C McLoughlin, Jonathan A Pushpa-Rajah, Donna Gillies, John Rathbone, Hannele Variend, Eliana Kalakouti, Katerina Kyprianou |
| Abstract |
Schizophrenia is a mental illness causing disordered beliefs, ideas and sensations. Many people with schizophrenia smoke cannabis, and it is unclear why a large proportion do so and if the effects are harmful or beneficial. It is also unclear what the best method is to allow people with schizophrenia to alter their cannabis intake. |
Twitter Demographics
The data shown below were collected from the profiles of 57 tweeters who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 10 | 18% |
| Japan | 5 | 9% |
| United States | 3 | 5% |
| Chile | 2 | 4% |
| Germany | 1 | 2% |
| India | 1 | 2% |
| Italy | 1 | 2% |
| Australia | 1 | 2% |
| Brazil | 1 | 2% |
| Other | 3 | 5% |
| Unknown | 29 | 51% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 46 | 81% |
| Practitioners (doctors, other healthcare professionals) | 7 | 12% |
| Scientists | 4 | 7% |
Mendeley readers
The data shown below were compiled from readership statistics for 393 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | <1% |
| United Kingdom | 1 | <1% |
| Denmark | 1 | <1% |
| Unknown | 389 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 57 | 15% |
| Researcher | 55 | 14% |
| Student > Master | 54 | 14% |
| Student > Ph. D. Student | 34 | 9% |
| Student > Postgraduate | 24 | 6% |
| Other | 61 | 16% |
| Unknown | 108 | 27% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 108 | 27% |
| Psychology | 52 | 13% |
| Nursing and Health Professions | 35 | 9% |
| Pharmacology, Toxicology and Pharmaceutical Science | 19 | 5% |
| Social Sciences | 13 | 3% |
| Other | 50 | 13% |
| Unknown | 116 | 30% |
Attention Score in Context
This research output has an Altmetric Attention Score of 111. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 June 2023.
All research outputs
#358,756
of 24,488,567 outputs
Outputs from Cochrane database of systematic reviews
#629
of 12,927 outputs
Outputs of similar age
#3,621
of 260,978 outputs
Outputs of similar age from Cochrane database of systematic reviews
#11
of 253 outputs
Altmetric has tracked 24,488,567 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,927 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 34.7. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 260,978 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 253 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.